Stock getting killed again!

Quote
Newsflash Moron, the market is crashing. High tech high science biotech has really gotten hammered, but Esperion has held up well. Losers always complain, winners look forward and find a way to win. The technical pattern coupled with the sheer compelling business/scientific outlook make this a no brainer.
 






anonymous said:
Newsflash Moron, the market is crashing. High tech high science biotech has really gotten hammered, but Esperion has held up well. Losers always complain, winners look forward and find a way to win. The technical pattern coupled with the sheer compelling business/scientific outlook make this a no brainer.
Click to expand...

Yes a "no brainer" indeed.
 






Now it's the technical pattern . Was it the technical pattern when the the stock was $78.00. When it was $78.00 big tech was doing well. Just accept thi is a dud with a pathetic plan and the worst launch in pharma in 10 years. This couldn'tnof gone worse. Your management colleagues are castoffs from other companies and could screw up a face- painting party for 5 yesr olds. Very embarassing what this company has accomplished since Feb of 2020. $4.83 is pathetic. This stock has been hovering in $4 to $5 range for months. Where is the techincal pattern? Is this the same as runway, uptick , etc. Please explain your business acumen so us laymen can understand how a stock can be down 90% in two years. We're waiting for the technical pattern.
 






Let’s just pretend you are a carton character and you got run over by a steamer roller. You are a flat, this equates to your non hire. Then miraculously you get up and you maintain several years of vendetta against the lipid experts… only to be flattened again. Looser.
 






Who are the lipid experts? You mean those stellar hires at the start that lasted 6 months with shitty sales? Or how about the inept RSM's that completely botched the hire process. Seems like a great bunch of losers were involved with this cluster fuck launch. Embarassing that some Ann Arbor twit thinks he's a lipid expert.
 






Finally high tech bioscience is getting a bid in the market, and Esperion is clearly a leader. Technical patterns and charts don’t lie, coupled with a compelling business rationale, this really sets up for a great second half of the year, look for a double before January
 






anonymous said:
Finally high tech bioscience is getting a bid in the market, and Esperion is clearly a leader. Technical patterns and charts don’t lie, coupled with a compelling business rationale, this really sets up for a great second half of the year, look for a double before January
Click to expand...
A hope you go to jail for your insider deception toward investors
 






Well this is a banner day for Esperion . Esperion officially got to $6.00 a share. After a year of bathtub farting and doing nothing the stock just took a monumental jump to $6.00 a share. Now $70.00 more to go. Great job Sheldon.
 












Top Bottom
Back
Quote